Creative Medical Technology Holdings, Inc.
CELZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001187953
No open-market purchases or sales by Creative Medical Technology Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $540.7K in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Creative Medical Technology Holdings, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- 0 vs. Q4 2025
- Shares held
- 96.8K
- +1.69K (+1.8%) vs. Q4 2025
- Total value
- $199.3K
- +$13.0K (+7.0%) vs. Q4 2025
- New holders
- 6
- 2 more added
- Sold out
- 6
- 2 more reduced
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CELZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $540.7K |
| Q1 2026 | 11 | $199.3K |
| Q4 2025 | 14 | $252.6K |
| Q3 2025 | 12 | $233.4K |
| Q2 2025 | 12 | $185.4K |
| Q1 2025 | 11 | $437.1K |
| Q4 2024 | 8 | $71.2K |
| Q3 2024 | 10 | $213.8K |
| Q2 2024 | 9 | $267.0K |
| Q1 2024 | 13 | $551.9K |
| Q4 2023 | 8 | $90.4K |
| Q3 2023 | 8 | $104.3K |
| Q2 2023 | 9 | $96.4K |
| Q1 2023 | 15 | $175.5K |
| Q4 2022 | 19 | $156.1K |
| Q3 2022 | 18 | $257.0K |
| Q2 2022 | 15 | $1.13M |
| Q1 2022 | 15 | $734.0K |
| Q4 2021 | 10 | $575.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Creative Medical Technology Holdings, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 38,290 | $78.9K | 0.00% | +9,823+34.5% | Added |
| Vanguard Capital Management LLC | 20,350 | $41.9K | 0.00% | +20,350 | New |
| XTX Topco Ltd | 14,260 | $29.4K | 0.00% | +14,260 | New |
| Susquehanna International Group, LLP | 10,469 | $21.6K | 0.00% | +10,469 | New |
| Vanguard Fiduciary Trust Co | 5,518 | $11.4K | 0.00% | +5,518 | New |
| Wells Fargo & Company | 5,000 | $10.3K | 0.00% | +5,000 | New |
| Tower Research Capital LLC (TRC) | 2,092 | $4.31K | 0.00% | −223−9.6% | Reduced |
| Morgan Stanley | 534 | $1.10K | 0.00% | +500+1,470.6% | Added |
| FMR LLC | 250 | $515 | 0.00% | +250 | New |
| UBS Group AG | 1 | $2 | 0.00% | −10−90.9% | Reduced |
| SBI Securities Co., Ltd. | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −30,205−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −17,460−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −10,319−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −5,132−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,130−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| Motiv8 Investments LLC | – | – | – | – | Not filed |